References
[1]Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association[J]. Pediatrics, 2004, 114(6): 1708-1733.
[2]王秀英,董海云,许毅,刘东海. 88例不完全川崎病的临床特点及随访分析[J]. 中国当代儿科杂志,2011,13(1):57-59.
[3]谢利剑,徐萌,黄敏,陈秀玉,李锦康,华仰德.547例川崎病临床分析及伴冠脉病变高危因素探讨[J]. 临床儿科杂志,2008,26(5):389-391.
[4]郭东更,宫怡.抗中性粒细胞胞浆抗体在风湿性疾病中的作用机制[J].临床荟萃,2006,21(24):1800.
[5]许洪平,何威逊,田国力.抗中性粒细胞胞抵浆抗体特异性靶抗原的检测在儿科临床中的应用[J].中国医学文摘·儿科学,2005,24(6):321-322.
[6]Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revision of diagnostic guidelines for Kawasadi disease (the 5th revised edition)[J]. Pediatr Int, 2005, 47(2): 232-234.
[7]中华儿科杂志编辑委员会.川崎病专题讨论会纪要[J].中华儿科杂志,2007,45(11):826-830.
[8]Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease[J]. Circulation, 2006, 113(22): 2606-2612.
[9]Davies DJ,Moran JE,Niall JF,Ryan GB.Segmetal necrotising glomemlonephfitis with antineutrophil antibody:possible arboviras aetiology?[J].Br Med J (Clin Res Ed), 1982, 285(6342): 606.
[10]李桂英,路学文.ANCA的秘密[J].国外医学泌尿系统分册,2002,21(2):54-57.
[11]Gross WL, Csernok E, Helmchem U. Antineutrophil cytoplasmic autoantbodies, autoantigens, and systemic vasculitis[J].APMIS, 1995, 103(2): 81-97.
[12]张晓时,何维敬. 抗中性粒细胞胞浆抗体及其相关系统性血管炎的研究进展[J]. 国外医学(临床生物化学与检验学分册), 2002, 23(2): 76-78.
[13]黄敏.不完全川崎病的诊断与治疗[J].临床儿科杂志,2008,26(10):912-914.
[14]陈新民.川崎病的诊断治疗现状[J]. 实用儿科临床杂志,2008,23(9): 719-720.